Human cytomegalovirus infection in lung transplant recipients triggers a CXCL-10 response

American Journal of Transplantation

Volumn 11, Issue 3, 2011, Pages 542-552

  Weseslindtner, L ^a   Nachbagauer, R ^a   Kundi, M ^a   Jaksch, P ^a   Kerschner, H ^a   Simon, B ^a   Hatos Agyi, L ^a   Scheed, A ^a   Aberle, J H ^a   Klepetko, W ^a   Puchhammer Stöckl, Elisabeth ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chemokines; CXCL 10; Cytomegalovirus; HCMV; IP 10; Lung transplantation

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; GANCICLOVIR; HYPERIMMUNE GLOBULIN; VALGANCICLOVIR; VIRUS DNA;

ADULT; AGED; AIRWAY OBSTRUCTION; ALLOGRAFT; ANTIVIRAL THERAPY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GRAFT RECIPIENT; HUMAN; HUMAN CYTOMEGALOVIRUS; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION;

EID: 79951968916     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03404.x     Document Type: Article

References (44)

1. Shah PD, McDyer JF. Viral infections in lung transplant recipients. Semin Respir Crit Care Med 2010; 31: 243-254.
2. Humar A, Snydman D. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009; 9(Suppl 4): S78-S86.
3. Zamora MR. Cytomegalovirus and lung transplantation. Am J Transplant 2004; 4: 1219-1226. (Pubitemid 39013567)
4. Streblow DN, Orloff SL, Nelson JA. Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol 2007; 19: 577-582. (Pubitemid 47464920)
5. Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Transplantation 2003; 75: 2064-2068. (Pubitemid 36793294)
6. Snyder LD, Finlen-Copeland CA, Turbyfill WJ, Howell D, Willner DA, Palmer SM. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med 2010; 181: 1391-1396.
7. Humar A, Michaels M. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006; 6: 262-274. (Pubitemid 43382161)
8. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097. (Pubitemid 34289682)
9. Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc 2009; 6: 54-65.
10. Belperio JA, Weigt SS, Fishbein MC, Lynch JP IIIrd. Chronic lung allograft rejection: Mechanisms and therapy. Proc Am Thorac Soc 2009; 6: 108-121.
11. Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355: 2032-2036. (Pubitemid 30339241)
12. Kerschner H, Jaksch P, Karigl G, Popow-Kraupp T, Klepetko W, Puchhammer-Stockl E. Cytomegalovirus DNA load patterns developing after lung transplantation are significantly correlated with long-term patient survival. Transplantation 2009; 87: 1720-1726.
13. Crough T, Khanna R. Immunobiology of human cytomegalovirus: From bench to bedside. Clin Microbiol Rev 2009; 22: 76-98.
14. Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, Ten Berge IJ. Primary immune responses to human CMV: A critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 2003; 101: 2686-2692. (Pubitemid 36857631)
15. Shlobin OA, West EE, Lechtzin N et al. Persistent cytomegalovirus- specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients. J Immunol 2006; 176: 2625-2634. (Pubitemid 43201715)
16. Gerna G, Lilleri D, Fornara C et al. Monitoring of human cytomegalovirus-specific CD4 and CD8 T cell immunity in patients receiving solid organ transplantation. Am J Transplant 2006; 6: 2356-2364. (Pubitemid 44359421)
17. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-568. (Pubitemid 28207705)
18. Loetscher M, Gerber B, Loetscher P et al. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184: 963-969.
19. Agostini C, Facco M, Siviero M et al. CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T cell alveolitis. Am J Respir Crit Care Med 2000; 162: 1466-1473.
20. Hokeness KL, Deweerd ES, Munks MW, Lewis CA, Gladue RP, Salazar-Mather TP. CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection. J Virol 2007; 81: 1241-1250. (Pubitemid 46167845)
21. Romagnani S. Regulation of the T cell response. Clin Exp Allergy 2006; 36: 1357-1366. (Pubitemid 44674119)
22. Qin S, Rottman JB, Myers P et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101: 746-754. (Pubitemid 28096070)
23. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 2002; 168: 3195-3204. (Pubitemid 34256349)
24. Oshansky CM, Barber JP, Crabtree J, Tripp RA. Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells. J Infect Dis 2010; 201: 1201-1207.
25. Neumann B, Emmanuilidis K, Stadler M, Holzmann B. Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation. Immunology 1998; 95: 512-521. (Pubitemid 28559141)
26. Sauty A, Dziejman M, Taha RA et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 1999; 162: 3549-3558. (Pubitemid 29313608)
27. Chan MC, Cheung CY, Chui WH et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005; 6: 135.
28. Miller AL, Bowlin TL, Lukacs NW. Respiratory syncytial virus-induced chemokine production: Linking viral replication to chemokine production in vitro and in vivo. J Infect Dis 2004; 189: 1419-1430. (Pubitemid 38543591)
29. Wark PA, Bucchieri F, Johnston SL et al. IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol 2007; 120: 586-593. (Pubitemid 47320759)
30. Spurrell JC, Wiehler S, Zaheer RS, Sanders SP, Proud D. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2005; 289: L85-L95. (Pubitemid 40863558)
31. Quint JK, Donaldson GC, Goldring JJ, Baghai-Ravary R, Hurst JR, Wedzicha JA. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD. Chest 2010; 137: 812-822.
32. Agostini C, Calabrese F, Rea F et al. CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol 2001; 158: 1703-1711. (Pubitemid 32422935)
33. Belperio JA, Keane MP, Burdick MD et al. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002; 169: 1037-1049. (Pubitemid 34753464)
34. Hoffman SA, Wang L, Shah CV et al. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant 2009; 9: 389-396.
35. Chan G, Bivins-Smith ER, Smith MS, Smith PM, Yurochko AD. Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J Immunol 2008; 181: 698-711.
36. Puchhammer-Stöckl E, Görzer I, Zoufaly A et al. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 2006; 81: 187-194.
37. Reiberger T, Aberle JH, Kundi M et al. IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection. Antivir Ther 2008; 13: 969-976.
38. Stacey AR, Norris PJ, Qin L et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009; 83: 3719-3733.
39. Chemaly RF, Yen-Lieberman B, Chapman J et al. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant 2005; 5: 544-548. (Pubitemid 40313346)
40. Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: A longitudinal study of lung transplant recipients. J Infect Dis 2004; 190: 1076-1083. (Pubitemid 39186793)
41. Skevaki CL, Christodoulou I, Spyridaki IS et al. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus. Clin Exp Allergy 2009; 39: 1700-1710.
42. Cristillo AD, Macri MJ, Bierer BE. Differential chemokine expression profiles in human peripheral blood T lymphocytes: Dependence on T cell coreceptor and calcineurin signaling. Blood 2003; 101: 216-225. (Pubitemid 36025911)
43. Streblow DN, Kreklywich C, Yin Q et al. Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J Virol 2003; 77: 2182-2194. (Pubitemid 36110031)
44. Belperio JA, Keane MP, Burdick MD et al. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 2003; 171: 4844-4852. (Pubitemid 37310606)